Compare CSV & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSV | MRVI |
|---|---|---|
| Founded | 1991 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 686.0M | 559.0M |
| IPO Year | 1996 | 2020 |
| Metric | CSV | MRVI |
|---|---|---|
| Price | $41.75 | $4.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $59.00 | $4.13 |
| AVG Volume (30 Days) | 91.5K | ★ 2.6M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.92% | N/A |
| EPS Growth | ★ 54.76 | 14.29 |
| EPS | ★ 0.84 | N/A |
| Revenue | ★ $417,440,000.00 | $185,743,000.00 |
| Revenue This Year | $7.35 | $12.54 |
| Revenue Next Year | $3.87 | $7.87 |
| P/E Ratio | $50.55 | ★ N/A |
| Revenue Growth | ★ 3.28 | N/A |
| 52 Week Low | $39.88 | $1.99 |
| 52 Week High | $52.10 | $5.00 |
| Indicator | CSV | MRVI |
|---|---|---|
| Relative Strength Index (RSI) | 32.39 | 68.22 |
| Support Level | $40.99 | $3.27 |
| Resistance Level | $44.87 | $5.00 |
| Average True Range (ATR) | 1.41 | 0.25 |
| MACD | -0.25 | 0.01 |
| Stochastic Oscillator | 0.00 | 81.91 |
Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise. The company enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum spaces and niches, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.